Program:
Start Year:
2025
Why did you choose Duke for your fellowship training?
I wanted a program where I would not only receive excellent clinical, surgical and research training but also grow overall as a person and member of my community. Very quickly into my first interview, I realized I could find all that an more with the gynecologic oncology fellowship at Duke.
What excites you about the fellowship program at Duke Obstetrics & Gynecology?
I am very excited to work with and learn from the amazing team here at Duke! I truly believe this training will prepare me to provide excellent care of my patients as a gynecologic oncologist and to serve as a mentor and educator for the future generations of medicine.
What are your career goals?
I aspire towards a career as an academic gynecologic oncologist active in research, medical education and service towards the betterment of the lives of my patients and their families.
What are your hobbies?
Running, travel, trying new foods and wrangling my nephew and niece!
Education & Training
Undergraduate school & graduation year:
University of Florida, 2015
Medical school & graduation year:
The Ohio State University College of Medicine, 2020
Residency & graduation year:
The Ohio State University, 2024
Awards and Honors
Hammond Research Fund Award 2025
SGO Outstanding Resident in Gynecologic Oncology 2024
Outstanding Resident Research Presentation 2024
Academic Chief Resident 2023-2024
Alpha Omega Alpha Honor Medical Society 2023
Department of Obstetrics and Gynecology, Outstanding 3rd Year Student 2020
Excellence in Global Health and Surgical Apprenticeship (Ho Chi Minh, Vietnam) 2020
Best Medical Education Poster OSU College of Medicine 2019
Publications
Brown M, Haight P, Ringel M, Phay J, Esnakula A, Vazzano J, Cosgrove C. 2024. Recurrent malignant struma ovarii presenting as peritoneal carcinomatosis in the setting of an intact thyroid: A case report and review of the literature. Gynecologic Oncology Reports. 54:101456. PMID 39076679
Bixel KL, Meade CE, Brown MD, Felix A.S. 2024. Adjuvant hormone therapy and overall survival among low-grade and apparent early-stage endometrial stromal sarcoma patients. Gynecologic Oncology Journal. PMID: 39727414. DOI: 10.3802/jgo.2025.36.e50
Riedinger C, Brown M, Haight P, Backes F, Cohn D, Goodfellow P, Cosgrove. 2023. Epigenetic MMR defect identifies a risk group not accounted for through traditional risk stratification algorithms in endometrial cancer. Frontiers in Oncology. 13:1147657. PMID: 37091179. DOI: 10.3389/fonc.2023.1147657
Calo C, Levine M, Brown M, O’Malley D, Backes F. 2023. Combination lenvatinib plus pembrolizumab in the pretreatment of ovarian clear cell carcinoma: A case series. Gynecologic Oncology Reports. 46:101171. PMID: 37065539. DOI: 10.1016/j.gore.2023.101171
Calo C, Barrington D, Brown MB, Gonzaelez L, Baek J, Huffman A, Benefict J, Backes F, Chambers L, Cohn D, Copeland L, Nagel C, O’Malley D, Bixel K. 2022. High pre-treatment neutrophil-to- lymphocyte ratio as a prognostic marker for worse survival in patients with recurrent metastatic cervical cancer treated with immune checkpoint inhibitors. Gynecologic Oncology Reports. 42:101040. PMID:35855965.
Barrington D, Calo C, Baek J, Brown M, Wagner V, Gonzales L, Huffman A, Benefict J, Bixel K. Beyond mismatch repair deficiency? Pre treatment neutrophil-to-lymphocyte ratio is associated with improved overall survival in patients with recurrent endometrial cancer treated with immunotherapy. 2022. Gynecologic Oncology. 166(3):522-529. PMID: 35907683. DOI: 10.1016/j.ygyno.2022.07.010
Brown, M, Akers A, Patterson J, Jaggers J, Paletta G, Capers Q, Mear A. Efficacy of Women in Medicine Mentorship Program on Female Acceptance Rate to US Medical Schools. 2019. AMWA: Centennial Congress of the Medical Women’s International Association
Presentations
Brown M, Balaskas K, Patterson J, Bahner D, Blumenfeld M. OB/GYN Ultrasound Community of Practice: A Novel Method to Increase Medical Student and Faculty Exposure to Ultrasound. 2019. 7th World Congress of Ultrasound in Medical Education. Irvine, CA.
Brown M, Akers A, Patterson J, Jaggers J, Paletta G, Meara A, Capers Q. Efficacy of Women in Medicine Mentorship Program on Female Acceptance Rate to US Medical Schools. 2018. OSU Fall Educational Symposium. Columbus, OH
Brown M, Khadraoui W, Fela E, Khan A, O’Malley D, Backes F, Nagel C. Taxane desensitization: an academic institution retrospective review. 2024. SGO. San Diego, CA
Haight P, Brown M, Espelien B, Chambers L, Backes F. Predictors of toxicity and response to treatment with Lenvatinib and pembrolizumab in patients with gynecologic malignancy. 2024. SGO. Olympic Valley, CA
Brown M, Riedinger C, Haight P, Backes F, Cohn D, Goodfellow J, Cosgrove C. Should mismatch repair status be incorporated into traditional risk stratification models for endometrial cancer. 2023. SGO. Tampa, FL
Brown M, Howell M, Prior A, Thung S, Bahner D. OB/GYN Community of Practice as an Elective to Increase Medical Student Exposure to Ultrasound. 2019. AIUM Convention. Orlando, FL
Brown M, Akers A, Patterson J, Jaggers J, Paletta G, Capers Q. Efficacy of Women in Medicine Mentorship Program on Female Acceptance Rate to US Medical Schools. 2019. OSU Internal Medicine Research Day. Columbus, OH
Research Interests
At current, I am interested in the identification and treatment of pre- and early-stage gynecologic cancers and possible prevention as well as developments in surgical technologies.